NextCure, Inc.

Ownership Transactions Reported by 18 Insiders

Symbol
NXTC on Nasdaq
Location
9000 Virginia Manor Road, Suite 200, Beltsville, MD

There are no Buy or Sell transactions made by insiders since 4/22/2024

NextCure, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Udayan Guha Chief Medical Officer Feb 1, 2025
Anne E. Borgman Director Jun 20, 2024
John Houston Director Jun 20, 2024
Timothy Mayer Chief Operating Officer Jan 31, 2025
Linda Liu SVP, Research Jan 31, 2022
Sourav Kundu Sr VP, Dev. & Mfg. Jan 31, 2025
Han Myint Chief Medical Officer Mar 29, 2024
Steven P. Cobourn Chief Financial Officer Jan 31, 2025
Kabakoff David S Director Jun 20, 2024
Elaine V. Jones Director Jun 20, 2024
Ellen Feigal Director Jun 20, 2024
Michael Richman President & CEO, Director Jan 31, 2025
Stella Xu Director Jun 24, 2021
Garry A. Nicholson Director Jun 22, 2023
Kevin G. Shaw Sr VP, General Counsel Jan 31, 2025
Sol Langermann Chief Scientific Officer Jan 31, 2025
Stephen W. Webster Director Jun 20, 2024
Chau Q. Khuong Director Jun 22, 2023

Recent Insider Transactions by Companies or Individuals for NextCure, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.